IL262180B2 - Compositions for topical application of compounds - Google Patents

Compositions for topical application of compounds

Info

Publication number
IL262180B2
IL262180B2 IL262180A IL26218018A IL262180B2 IL 262180 B2 IL262180 B2 IL 262180B2 IL 262180 A IL262180 A IL 262180A IL 26218018 A IL26218018 A IL 26218018A IL 262180 B2 IL262180 B2 IL 262180B2
Authority
IL
Israel
Prior art keywords
extract
composition
skin
active agent
fragment
Prior art date
Application number
IL262180A
Other languages
English (en)
Hebrew (he)
Other versions
IL262180A (en
IL262180B1 (en
Original Assignee
Illustris Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illustris Pharmaceuticals Inc filed Critical Illustris Pharmaceuticals Inc
Publication of IL262180A publication Critical patent/IL262180A/en
Publication of IL262180B1 publication Critical patent/IL262180B1/en
Publication of IL262180B2 publication Critical patent/IL262180B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/61—Surface treated
    • A61K2800/62—Coated
    • A61K2800/624—Coated by macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL262180A 2016-04-12 2017-04-12 Compositions for topical application of compounds IL262180B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662321626P 2016-04-12 2016-04-12
PCT/US2017/027275 WO2017180788A1 (en) 2016-04-12 2017-04-12 Compositions for topical application of compounds

Publications (3)

Publication Number Publication Date
IL262180A IL262180A (en) 2018-11-29
IL262180B1 IL262180B1 (en) 2025-08-01
IL262180B2 true IL262180B2 (en) 2025-12-01

Family

ID=59999163

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262180A IL262180B2 (en) 2016-04-12 2017-04-12 Compositions for topical application of compounds

Country Status (11)

Country Link
US (2) US20170290778A1 (enExample)
EP (1) EP3442488A4 (enExample)
JP (1) JP2019513799A (enExample)
KR (1) KR20190022476A (enExample)
CN (1) CN109152702A (enExample)
AU (1) AU2017250267A1 (enExample)
CA (1) CA3020400A1 (enExample)
IL (1) IL262180B2 (enExample)
MX (1) MX2018012486A (enExample)
SG (1) SG11201808990QA (enExample)
WO (1) WO2017180788A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
CN102869373B (zh) 2009-06-25 2017-05-10 雷文斯治疗公司 不含白蛋白的肉毒杆菌毒素制剂
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
JP7217700B2 (ja) 2016-09-13 2023-02-03 アラーガン、インコーポレイテッド 安定化非タンパク質クロストリジウム毒素組成物
US11040090B2 (en) * 2016-12-08 2021-06-22 Prime Bio, Inc Botulinum neurotoxin compositions
CA3078631A1 (en) * 2017-10-11 2019-04-18 Jacob M. Waugh Methods and compositions for topical delivery
CN119157876A (zh) 2017-12-15 2024-12-20 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
KR102189632B1 (ko) * 2018-03-09 2020-12-11 전남대학교산학협력단 신규 균주 페니실리움 애시둠 및 이의 용도
KR101899413B1 (ko) * 2018-05-03 2018-09-18 주식회사 케어사이드 피부 감염의 예방 또는 치료용 조성물
WO2020004234A1 (ja) 2018-06-26 2020-01-02 久光製薬株式会社 マイクロニードルデバイス及びそれを製造する方法
KR102088104B1 (ko) * 2018-06-29 2020-03-11 호서대학교 산학협력단 개망초 꽃 에센셜 오일을 포함하는 신경 근육 관련 질환 예방 및 치료용 조성물
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
CN111825775B (zh) * 2019-04-18 2021-11-02 复旦大学 密枝圆柏多糖及其制备方法和在制备抗肿瘤药物中的用途
CN110090193B (zh) * 2019-05-14 2022-04-12 东方爱堡(北京)母婴健康科技有限公司 一种具有减脂功效的祛痘保湿精华液及其制备方法
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
EP4081540A4 (en) * 2019-12-24 2024-01-31 Dyve Biosciences, Inc. TOPICAL CYCLOSPORINE FOR THE TREATMENT OF PSORIASIS AND OTHER DISEASES
CN111281980B (zh) * 2020-02-05 2025-01-24 芽米科技(广州)有限公司 一种水溶性γ-聚谷氨酸-替米考星复合物及其制备方法
CN111110831B (zh) * 2020-02-20 2023-08-08 柳州市工人医院 一种溃疡糊剂及其制备方法
CN111297884B (zh) * 2020-04-02 2021-03-30 中国农业科学院蜜蜂研究所 腺苷在蜜蜂病毒感染防治中的应用
CN111329846A (zh) * 2020-04-24 2020-06-26 云南伦扬科技有限公司 一种阴道杀菌贴膜及其制备方法
CN111587861A (zh) * 2020-05-21 2020-08-28 广州市穗升有害生物防治中心 引诱箱
KR20240127867A (ko) * 2020-08-10 2024-08-23 지로파, 인코포레이티드 국소 전달을 위한 조성물 및 방법
KR20240125432A (ko) * 2020-09-29 2024-08-19 지로파, 인코포레이티드 통증 완화 및 마취를 위한 조성물 및 방법
JP2023546445A (ja) * 2020-10-22 2023-11-02 ファイザー・インク コルチコステロイドの非経口投与のためのｐｅｇフリー水性懸濁液
CN114617974B (zh) * 2020-12-10 2023-10-03 中国科学院苏州纳米技术与纳米仿生研究所 一种多肽白蛋白纳米粒及其制备方法和应用
HU231397B1 (hu) 2021-01-22 2023-06-28 Egis Gyógyszergyár Zrt. Pregabalint tartalmazó topikális gyógyszerkészítmény
MX2023008647A (es) 2021-01-22 2023-08-01 Egyt Gyogyszervegyeszeti Gyar Formulacion topica que contiene pregabalina dispersada.
JP2024506865A (ja) * 2021-02-05 2024-02-15 モダン メドウ，インコーポレイテッド スキンケア組成物及びその使用方法
WO2022232161A1 (en) * 2021-04-26 2022-11-03 Sypherion, Llc Inhibitors of nsp1 for treatment of sars-cov-2
CN113332238A (zh) * 2021-06-09 2021-09-03 四川恒通动保生物科技有限公司 一种加米霉素的复合溶液剂的制备方法
JP7141025B1 (ja) * 2021-11-11 2022-09-22 エルデシエロ プライベート リミテッド 化合物、組成物、方法、及び製造方法
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
CN117088938A (zh) * 2022-05-13 2023-11-21 四川省中医药科学院 一种对抗细胞因子风暴或细胞因子释放综合征的麝香提取物及其制备方法和应用
CN117186177B (zh) * 2022-05-31 2024-08-23 中国农业大学 一种具有降尿酸活性的鸭血球蛋白肽及其制备方法
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
WO2024007014A2 (en) * 2022-06-30 2024-01-04 Board Of Trustees Of The University Of Arkansas Process for treating livestock exposed to toxic forage using melatonin compositions
CN117582442A (zh) * 2022-08-18 2024-02-23 智泽童康(广州)生物科技有限公司 双嘧达莫在制备防治蚊虫叮咬的产品中的应用
AU2023352919A1 (en) 2022-09-29 2025-03-13 Adora Life Science, Inc. Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
CN116098882A (zh) * 2023-04-06 2023-05-12 山东诚创蓝海医药科技有限公司 一种含利多卡因丙胺卡因的组合物及其制备方法
CN116791274B (zh) * 2023-06-16 2026-03-27 福建恒安集团有限公司 一种超柔软爽滑纯棉无纺布的制备方法及其应用
CN116870001B (zh) * 2023-08-11 2024-08-27 云南中医药大学 吲哚-3-甲酸衍生物与氟康唑联合在制备抗耐药白念珠菌药物中的应用
CN117838583B (zh) * 2023-09-28 2026-08-11 山东福瑞达生物股份有限公司 一种抗光老化护肤组合物及其制备方法和应用
CN117427027B (zh) * 2023-12-21 2024-04-23 舒芙雅生物科技有限公司 一种祛痘组合物及其制备方法
US12357725B1 (en) 2024-05-30 2025-07-15 King Saud University Clinical dressing loaded with coffee extract
CN120284984B (zh) * 2025-04-25 2025-10-17 首都医科大学附属北京胸科医院 一种抗结核分枝杆菌感染的化合物及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100124573A1 (en) * 2008-11-14 2010-05-20 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
US20100135935A1 (en) * 2008-11-28 2010-06-03 Leshchiner Adelya K Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
CA2703532A1 (en) * 2010-05-10 2011-11-10 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
WO2014134532A1 (en) * 2013-02-28 2014-09-04 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
US20160000634A1 (en) * 2013-03-05 2016-01-07 Dante Liberatoscioli Apparatus for relieving back pain

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
US8728510B1 (en) * 2002-03-15 2014-05-20 Advanced Cardiovascular Systems, Inc. Biocompatible carrier containing a bioadhesive material
US7956180B2 (en) * 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
WO2006063021A2 (en) * 2004-12-07 2006-06-15 Surmodics, Inc. Coatngs with crystallized active agents (s)
US7727537B2 (en) * 2005-02-14 2010-06-01 Dpm Therapeutics Corp. Stabilized compositions for topical administration and methods of making same
ES2747978T3 (es) * 2005-10-03 2020-03-12 Mark A Pinsky Liposomas no fosfolipídicos que comprenden ácido hialurónico
AU2006352358B2 (en) * 2006-12-26 2014-03-13 Bomi Patel Framroze Skin lightening composition for hyperpigmented skin
US20100272697A1 (en) * 2007-04-10 2010-10-28 Ali Naji Pancreatic islet cells composition and methods
JP5261680B2 (ja) * 2007-08-09 2013-08-14 キッコーマンバイオケミファ株式会社 ヒアルロン酸プロピレングリコールエステルおよびそれを用いた皮膚外用剤
DE102008034265A1 (de) * 2008-07-22 2010-01-28 Beiersdorf Ag Wirkstoffkombination aus Anisfruchtextrakt und Hyaluronsäure
EP3205344A1 (en) * 2009-05-19 2017-08-16 Plurogen Therapeutics, LLC Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing
CA2762212C (en) * 2009-05-20 2015-12-29 Humacyte, Inc. Elastin for soft tissue augmentation
US20110305737A1 (en) * 2010-06-09 2011-12-15 NY Derm LLC Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology
FR2971711B1 (fr) * 2011-02-18 2014-06-13 Isp Investments Inc Composition cosmetique comprenant un extrait de petit epeautre en tant qu'agent activateur de la synthese des proteines de la matrice extracellulaire
EP2961945B1 (en) * 2013-02-28 2020-09-02 United Technologies Corporation Method and apparatus for collecting pre-diffuser airflow and routing it to combustor pre-swirlers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100124573A1 (en) * 2008-11-14 2010-05-20 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
US20100135935A1 (en) * 2008-11-28 2010-06-03 Leshchiner Adelya K Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
CA2703532A1 (en) * 2010-05-10 2011-11-10 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
WO2014134532A1 (en) * 2013-02-28 2014-09-04 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
US20160000634A1 (en) * 2013-03-05 2016-01-07 Dante Liberatoscioli Apparatus for relieving back pain

Also Published As

Publication number Publication date
CN109152702A (zh) 2019-01-04
MX2018012486A (es) 2019-06-06
KR20190022476A (ko) 2019-03-06
CA3020400A1 (en) 2017-10-19
AU2017250267A1 (en) 2018-11-08
SG11201808990QA (en) 2018-11-29
EP3442488A4 (en) 2020-03-25
JP2019513799A (ja) 2019-05-30
US20190008795A1 (en) 2019-01-10
US20170290778A1 (en) 2017-10-12
IL262180A (en) 2018-11-29
EP3442488A1 (en) 2019-02-20
WO2017180788A1 (en) 2017-10-19
IL262180B1 (en) 2025-08-01

Similar Documents

Publication Publication Date Title
US20190008795A1 (en) Compositions for topical application of compounds
AU2018347514C1 (en) Methods and compositions for topical delivery
US20230001128A1 (en) Aerosolization systems, methods, and apparatuses
CA2939259C (en) Basidiomycete-derived cream for treatment of skin diseases
CN115003279A (zh) 前药组合物和治疗方法
TW201043280A (en) Pharmaceutical system for trans-membrane delivery
CN104159594A (zh) 用于皮肤病治疗的凯莫瑞c15肽的局部制剂
JP2013516482A (ja) 局所経皮用デクスメデトミジン組成物およびそれらの使用方法
DE112013001457T5 (de) Transdermales Applikationssystem
HUE026994T2 (en) Liquid nasal spray containing low dose naltrexone
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
JPS60152413A (ja) メントールにより経皮性薬剤放出の強化を行なつた局所用組成物
PL188153B1 (pl) Lek zawierający nośnik materiałowy zaopatrzony w informację o biologicznie aktywnej substancji
CN109998994A (zh) 包含药物的柔性脂质体及其制备方法
WO2022247922A1 (zh) 一种藏药组合物在制备预防和/或治疗糖尿病性周围神经病变的药物中的应用
CN115554243B (zh) 一种治疗玫瑰痤疮的米诺环素泡沫剂
US11065206B2 (en) Topical formulations including lipid microcapsule delivery vehicles and their uses
EP3675814A1 (de) Zusammensetzung zur topischen behandlung von nicht-mikroorganismus-verursachten entzündlichen haut- und schleimhauterkrankungen
CN109381466A (zh) 促进糖尿病病人伤口愈合的治疗剂
RU2316333C1 (ru) Биологически активная добавка к средству для оздоровительно-восстановительных косметических панто-магниевых ванн и средство для оздоровительно-восстановительных косметических панто-магниевых ванн на ее основе
Doshi Preparation and evaluation of intraoral drug delivery system for the treatment of asthma
Shivaraj Formulation and Evaluation of Transdermal Drug Delivery System of an Antiallergic Drug
SRINIVASA Design and Evaluation of Matrix Type Transdermal Delivery System of Antihypertensive Drug from Conjugated Polymer
CN106551931A (zh) 1-羟基-2-吡啶酮类化合物在制备口腔黏膜疾病治疗药物上的用途
JPS5959615A (ja) 粘着性貼付製剤用膏体